(Q45912795)

English

Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder.

scientific article published on 16 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

author name string

Irina Mezhebovsky

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

Kairi Mägi

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

Fahua She

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

Catherine Datto

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

Hans Eriksson

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

language of work or name

0 references

publication date

16 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

International Journal of Geriatric Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

28

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

615-625

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Anxiety symptoms and generalized anxiety disorder in the elderly: a review

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Sleep disorders and their impacts on healthy, dependent, and frail older adults.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Current considerations in the treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Psychopharmacology: number needed to treat: an underused measure of treatment effect

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

DSM-IV criteria for generalized anxiety disorder in older adults: distinguishing the worried from the well

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Generalized anxiety disorder: prevalence, burden, and cost to society.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

New Evidence on Benzodiazepine Use and Falls: The Time Factor

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

21 January 2018

Implications of the CATIE trial on treatment: extrapyramidal symptoms

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

7 January 2021

based on heuristic

inferred from DOI database lookup

First-line pharmacotherapy approaches for generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for falls during treatment of late-life depression.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

7 January 2021

based on heuristic

inferred from DOI database lookup

Measures of depression in older adults with generalized anxiety disorder: a psychometric evaluation

1 reference

https://api.crossref.org/works/10.1002%2FGPS.3867

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GPS.3867

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23070803

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45912795&oldid=1457844005"